Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2025-12-24 @ 11:45 PM
NCT ID: NCT07216651
Eligibility Criteria: Inclusion Criteria: 1. Participants must be 18 years or older. 2. Participants must have a diagnosis of either obesity or overweight. 3. Participants must have initiated first-time semaglutide treatment within the past 4-12 weeks for the management of overweight or obesity, in line with United States Prescribing Information (USPI) and the clinical judgment of the responsible Healthcare Professional (HCP). 4. Participants must have access to and be able to use suitable weighing scales to record their weight before or during consultations. 5. Participants must provide written informed consent to participate in this study, including agreeing to adhere to the associated procedures. Exclusion Criteria: 1. Participants with conditions that the Healthcare Professional (HCP) deems would prevent effective use of weighing scales and accurate self-monitoring or reporting of body weight. 2. Failure to satisfy the responsible Healthcare Professional (HCP) of fitness to participate for any other reason.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT07216651
Study Brief:
Protocol Section: NCT07216651